Atlas Trials

TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation

Clinical trial NCT05091723 · COMPLETED

Trial details

NCT number
NCT05091723
Sponsor
Theravance Biopharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)
Start date
2021-10-13
Primary completion
2021-11-24
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.